The goal of this study was to examine the neuroprotective effect of ebselen against intracerebroventricular streptozotocin (ICV-STZ)-induced oxidative stress and neuronal apoptosis in rat brain. A total of 30 adult male Sprague-Dawley rats were randomly divided into 3 groups of 10 animals each: control, ICV-STZ, and ICV-STZ treated with ebselen. The ICV-STZ group rats were injected bilaterally with ICV-STZ (3 mg/kg) on days 1 and 3, and ebselen (10 mg/kg/day) was administered for 14 days starting from 1st day of ICV-STZ injection to day 14. Rats were killed at the end of the study and brain tissues were removed for biochemical and histopathological investigation. Our results demonstrated, for the first time, the neuroprotective effect of ebselen on Alzheimer’s disease (AD) model in rats. Our present study, in ICV-STZ group, showed significant increase in tissue malondialdehyde levels and significant decrease in enzymatic antioxidants superoxide dismutase and glutathione peroxidase in the frontal cortex tissue. The histopathological studies in the brain of rats also supported that ebselen markedly reduced the ICV-STZ-induced histopathological changes and well preserved the normal histological architecture of the frontal cortex tissue. The number of apoptotic neurons was increased in frontal cortex tissue after ICV-STZ administration. Treatment of ebselen markedly reduced the number of degenerating apoptotic neurons. The study demonstrates the effectiveness of ebselen, as a powerful antioxidant, in preventing the oxidative damage and morphological changes caused by ICV-STZ in rats. Thus, ebselen may have a therapeutic value for the treatment of AD.
AgrawalaRMishraaBTyagiaENathbCShuklaaR (2010) Effect of curcumin on brain insulin receptors and memory functions in STZ (ICV) induced dementia model of rat. Pharmacological Research61: 247–252.
2.
AlievGSmithMAde la TorreJCPerryG (2004) Mitochondria as a primary target for vascular hypoperfusion and oxidative stress in Alzheimer's disease. Mitochondrion4(5–6): 649–663.
3.
ApelKHirtH (2004) Reactive oxygen species: metabolism, oxidative stress, and signal transduction. Annual Review of Plant Physiology55: 373–399.
4.
AshokBTAliR (1999) The aging paradox: free radical theory of aging. Experimental Gerontology34: 293–303.
5.
BaldeirasISantanaIProencaMTGarruchoMHPascoalRRodriguesA. (2008) Peripheral oxidative damage in mild cognitive impairment and mild Alzheimer’s disease. Journal of Alzheimer Disease15: 117–128.
6.
BursztajnSHDeSouzaRMcPhieDLBermanSAShioiJRobakisNK. (1998) Overexpression in neurons of human presenilin-1 or a presenilin-1 familial Alzheimer disease mutant does not enhance apoptosis. Journal of Neuroscience18: 9790–9799.
7.
ButterfieldDA (2004) Proteomics: a new approach to investigate oxidative stress in Alzheimer's disease brain. Brain Research1000: 1–7.
8.
CakatayUKayaliRUzunH (2008) Relation of plasma protein oxidation parameters and paraoxonase activity in the ageing population. Clinical and Experimental Medicine8: 51–57.
9.
CenturiaoFBCorteCLPaixaoMWBragaALZeniGEmanuelliT. (2005) Effect of ebselen and organochalcogenides on excitotoxicity induced by glutamate in isolated chick retina. Brain Research1039: 146–152.
10.
ChonpathompikunlertPWattanathornJMuchimapuraS (2010) Piperine, the main alkaloid of Thai black pepper, protects against neurodegeneration and cognitive impairment in animal model of cognitive deficit like condition of Alzheimer’s disease. Food and Chemical Toxicology48: 798–802.
11.
CotgreaveIAJohanssonUWestergrenGMoldeusPWBrattsandR (1988) The anti-inflammatory activity of Ebselen but not thiols in experimental alveolitis and bronchiolitis. Agents and Actions24: 313–319.
12.
DeshmukhRSharmaVMehanSSharmaNBediKL (2009) Amelioration of intracerebroventricular streptozotocin induced cognitive dysfunction and oxidative stress by vinpocetine-a PDE1 inhibitor. European Journal of Pharmacology620: 49–56.
13.
DringenR (2000) Metabolism and functions of glutathione in brain (Review). Progress in Neurobiology62: 649–671.
14.
DringenRGuttererJMHirrlingerJ (2000) Glutathione metabolism in brain metabolic interaction between astrocytes and neurons in the defense against reactive oxygen species. European Journal of Biochemistry267: 4912–4916.
15.
DrögeWKinscherfR (2008) Aberrant insulin receptor signaling and amino acid homeostasis as amajor cause of oxidative stress in aging. Antioxidants and Redox Signaling10: 661–678.
16.
DuelliRSchrockHKuschinskyWHoyerS (1994) Intracerebroventricular injection of streptozotocin induces discrete local changes in cerebral glucose utilization in rats. International Journal of Developmental Neuroscience12: 737–743.
17.
FreudeBMastersTNRobicsekFFokinAKostinSZimmermannR. (2000) Apoptosis is initiated by myocardial ischemia and executed during reperfusion. Journal of Molecular and Cellular Cardiology32: 197–208.
18.
Garcia-SeguraLM (2009) Hormones and brain plasticity. New York, NY: Oxford University Press.
19.
GuoQFuWXieJLuoHSellsSFGeddesJW. (1998) Par-4 is a mediator of neuronal degeneration associated with the pathogenesis of Alzheimer disease. Nature Medicine4: 957–962.
20.
HalliwellB (2001) Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment. Drugs and Aging18: 685–716.
21.
HattoriNKitagawaKHigashidaTYagyuKShimohamaSWatayaT. (1998) Cl-ATPase and Na+/K(+)-ATPase activities in Alzheimer's disease brains. Neuroscience Letters254: 141–144.
22.
HoyerSLannertH (1999) Inhibition of the neuronal insulin receptor causes Alzheimer-like disturbances in oxidative/energy brain metabolism and in behavior in adult rats. Annals of the New York Academy of Sciences893: 301–303.
23.
ImaiHMasayasuHDewarDGrahamDIMacraeIM (2001) Ebselen protects both gray and white matter in a rodent model of focal cerebral ischemia. Stroke32: 2149–2154.
24.
IshratTHodaNKhanMBYousufSAhmadMKhanM. (2009a) Amelioration of cognitive deficits and neurodegeneration by curcumin in rat model of sporadic dementia of Alzheimer's type (SDAT). European Neuropsychopharmacology19: 636–647.
25.
IshratTParveenKKhanMKhuwajaGKhanBYousufS. (2009b) Selenium prevents cognitive decline and oxidative damage in rat model of streptozotocin-induced experimental dementia of Alzheimer's type. Brain Research1281: 117–127.
26.
KalayciMCoskunOCagaviFKanterMArmutcuFGulS. (2005) Neuroprotective effects of ebselen on experimental spinal cord injury in rats. Neurochemical Research30(3): 403–410.
27.
LannertHHoyerS (1998) Intracerebroventricular administration of streptozotocin causes long-term diminutions in learning and memory abilities and in cerebral energy metabolism in adult rats. Behavioral Neuroscience112: 1199–1208.
28.
LeeJMZipfelGJChoiDW (1999) The changing landscape of ischaemic brain injury mechanisms. Nature399: 7–14.
29.
Lester-CollNRiveraEJSosciaSJDoironKWandsJRde la MonteSM (2006) Intracerebral streptozotocin model of type 3 diabetes: relevance to sporadic Alzheimer’s disease. Journal of Alzheimer Disease9: 13–33.
30.
LongZZhengMZhaoLXiePSongCChuY. (2013) Valproic acid attenuates neuronal loss in the brain of APP/PS1 double transgenic Alzheimer's disease mice model. Current Alzheimer Research10(3): 261–269.
31.
LowryOHRosebroughNJFarrALRandallRI (1951) Protein measurement with the folin phenol reagent. Journal of Biological Chemistry193: 265–275.
32.
LyketsosCGLopezOJonesBFitzpatrickALBreitnerJDekoskyS (2002) Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study. Journal of the American Medical Association288: 1475–1483.
33.
MarianiEPolidoriMCCherubiniAMecocciP (2005) Oxidative stress in brain aging, neurodegenerative and vascular diseases: an overview. Journal of Chromatography, B: Analytical Technologies in the Biomedical and Life Sciences827: 65–75.
34.
MarkesberyWR (1997) Oxidative stress hypothesis in Alzheimer’s disease. Free Radical Biology and Medicine23(1): 134–147.
35.
MaulikNYoshidaTDasDK (1998) Oxidative stress developed during the reperfusion of ischemic myocardium induces apoptosis. Free Radical Biology and Medicine24: 869–875.
36.
MeisterA (1988) Glutathione metabolism and its selective modification. Journal of Biological Chemistry263: 17205–17208.
37.
MoussaouiSObinuMCDanielNReibaudMBlandchardVImperatoA. (2000) The antioxidant ebselen prevents neurotoxicity and clinical symptoms in a primate model of Parkinson’s disease. Experimental Neurology166: 235–245.
38.
NelsonVMDancikCMPanWJiangZGLebowitzMSGhanbariHA (2009) PAN-811 inhibits oxidative stress-induced cell death of human Alzheimer’s disease-derived and age-matched olfactory neuroepithelial cells via suppression of intracellular reactive oxygen species. Journal of Alzheimer Disease17: 611–619.
39.
NitaDANitaVSpulberSMoldovanMPopaDPZagreanAM. (2001) Oxidative damage following cerebral ischemia depends on reperfusion a biochemical study in rat. Journal of Cellular and Molecular Medicine5: 163–170.
40.
NobakhtMHoseiniSMMortazaviPSohrabiIEsmailzadeBRooshandelNR. (2011) Neuropathological changes in brain cortex and hippocampus in a rat model of Alzheimer’s disease. Iranian Biomedical Journal15(1&2): 51–58.
41.
OhkawaHOhishiNYagiK (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid rection. Analytical Biochemistry95: 351–358.
42.
PagliaDEValentineWN (1967) Studies on the quantitative and qualitative characterisation of erythrocyte glutathione peroxidase. Journal of Laboratory and Clinical Medicine70: 158–169.
43.
ParnhamMSiesH (2000) Ebselen: prospective therapy for cerebral ischaemia. Expert Opinion on Investigational Drugs9: 607–619.
44.
PerryGNunomuraAHiraiKZhuXPérezMAvilaJ. (2002) Is oxidative damage the fundamental pathogenic mechanism of Alzheimer's and other neurodegenerative diseases?Free Radical Biology and Medicine33(11): 1475–1479.
45.
PlaschkeKHoyerS (1993) Action of the diabetogenic drug streptozotocin on glycolytic and glycogenolytic metabolism in adult rat brain cortex and hippocampus. International Journal of Developmental Neuroscience11: 477–483.
46.
PorciunculaLORochaJBBoeckCRVenditeDSouzaDO (2001) Ebselen prevents excitotoxicity provoked by glutamate in rat cerebellar granule neurons. Neuroscience Letters299: 217–220.
47.
PorciunculaLORochaJBCimarostiHVinadeLGhisleniGSalbegoCG. (2003) Neuroprotective effect of ebselen on rat hippocampal slices submitted to oxygen-glucose deprivation: correlation with immunocontent of inducible nitric oxide synthase. Neuroscience Letters346: 101–104.
48.
RenXYangLLiuJSuDYouDLiuC. (2001) A novel glutathione peroxidase mimic with antioxidant activity. Archives of Biochemistry and Biophysics387: 250–256.
49.
RossierBCGeeringKKraenbuhlJP (1987) Regulation of the sodium pump: how and why?Trends in Biochemical Sciences2: 483–487.
50.
SaitoIAsanoTSanoKTakakuraKAbeHYoshimotoT. (1998) Neuroprotective effect of an antioxidant, ebselen, in patients with delayed neurological deficits after aneurysmal subarachnoid hemorrhage. Neurosurgery42: 269–278.
51.
SatohTIshigeKSagaraY (2004) Protective effects on neuronal cells of Mouse afforded by ebselen against oxidative stress at multiple steps. Neuroscience Letters371: 1–5.
52.
SharmaMGuptaYK (2001) Effect of chronic treatment of melatonin on learning, memory and oxidative deficiencies induced by intracerebroventricular streptozotocin in rats. Pharmacology Biochemistry and Behavior70: 325–331.
53.
SharmaNDeshmukhRBediKL (2010) SP600125, a competitive inhibitor of JNK attenuates streptozotocin induced neurocognitive deficit and oxidative stress in rats. Pharmacology Biochemistry and Behavior96: 386–394.
54.
SharmaVBalaADeshmukhRBediKLSharmaPL (2012) Neuroprotective effect of RO-20-1724-a phosphodiesterase4 inhibitor against intracerebroventricular streptozotocin induced cognitive deficit and oxidative stress in rats. Pharmacology Biochemistry and Behavior101: 239–245.
55.
ShohamSBejarCKovalevESchorer-ApelbaumDWeinstockM (2007) Ladostigil prevents gliosis, oxidative-nitrative stress and memory deficits induced by intracerebroventricular injection of streptozotocin in rats. Neuropharmacology52: 836–843.
56.
SiesH (1993) Ebselen, a selenoorganic compound as glutathione peroxidase mimic. Free Radical Biology and Medicine14: 313–323.
57.
SiesHArteelGE (2000) Interaction of peroxynitrite with selenoproteins and glutathione peroxidase mimics. Free Radical Biology and Medicine28: 1451–1455.
58.
SiesHMasumotoH (1997) Ebselen as a glutathione peroxidase mimic and as a scavenger of peroxynitrite. Advances in Pharmacology38: 229–246.
59.
SunY (1990) Free radicals, antioxidant enzymes, and carcinogenesis. Free Radical Biology and Medicine8: 583–599.
60.
SunYOberleyLWLiY (1988) A simple method for clinical assay of superoxide dismutase. Clinical Chemistry34: 497–500.
61.
SzkudelskiT (2001) The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiological Research50: 537–546.
62.
TakasagoTPetersEEGrahamDIMasayasuHMacraeIM (1997) Neuroprotective efficacy of ebselen an antioxidant with anti-inflammatory actions, in a rodent model of permanent middle cerebral artery occlusion. British Journal of Pharmacology122: 1251–1256.
63.
YamagataKIchinoseSMiyashitaATagamiM (2008) Protective effects of ebselen, a seleno-organic antioxidant on neurodegeneration induced by hypoxia and reperfusion in stroke-prone spontaneously hypertensive rat. Neuroscience153: 428–435.
64.
YamaguchiTSanoKTakakuraKSaitoIShinoharaYAsanoT. (1998) Ebselen in acute ischemic stroke: a placebo-controlled, double-blind clinical rial. Stroke29: 12–17.
65.
YoshizumiMKogameTSuzakiYFujitaYKyawMKirimaK. (2002) Ebselen attenuates oxidative stress-induced apoptosis via the inhibition of the c-Jun N-terminal kinase and activator protein-1 signalling pathway in PC12 cells. British Journal of Pharmacology136: 1023–1032.
66.
YuBPYangR (1996) Critical evaluation of the free radical theory of aging. A proposal for the oxidative stress hypothesis. Annals of the New York Academy of Sciences786: 1–11.
67.
ZengGFZhangZYLuLXiaoDQZongSHHeJM (2013) Protective effects of ginger root extract on Alzheimer disease-induced behavioral dysfunction in rats. Rejuvenation Research16(2): 124–133.
